Literature DB >> 18783317

Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission.

Gregory J Mertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18783317     DOI： 10.1086/591914

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.

Authors:  Sita Awasthi; Gregory G Mahairas; Carolyn E Shaw; Meei-Li Huang; David M Koelle; Christine Posavad; Lawrence Corey; Harvey M Friedman
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

3.  Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.

Authors:  Elizabeth Tronstein; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Terri Warren; Lawrence Corey; Anna Wald
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

4.  Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Authors:  D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

5.  Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity.

Authors:  Chaya D Patel; Sean A Taylor; Jesse Mehrbach; Sita Awasthi; Harvey M Friedman; David A Leib
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

6.  Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

Authors:  David I Bernstein; Julie D Earwood; Fernando J Bravo; Gary H Cohen; Roselyn J Eisenberg; Jennifer R Clark; Jeffrey Fairman; Rhonda D Cardin
Journal:  Vaccine       Date:  2011-01-14       Impact factor: 3.641

7.  Adolescents' and young women's use of a microbicide surrogate product when receiving oral sex.

Authors:  Beth A Auslander; Marina Catallozzi; Gray Davis; Paul A Succop; Lawrence R Stanberry; Susan L Rosenthal
Journal:  J Pediatr Adolesc Gynecol       Date:  2013-12-04       Impact factor: 1.814

8.  Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.

Authors:  M J Keller; A M Malone; C A Carpenter; Y Lo; M Huang; L Corey; R Willis; C Nguyen; S Kennedy; M Gunawardana; D Guerrero; J A Moss; M M Baum; T J Smith; B C Herold
Journal:  J Antimicrob Chemother       Date:  2012-05-03       Impact factor: 5.790

9.  The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.

Authors:  David I Bernstein; Nicholas Farley; Fernando J Bravo; Julie Earwood; Monica McNeal; Jeff Fairman; Rhonda Cardin
Journal:  Vaccine       Date:  2009-10-24       Impact factor: 3.641

10.  An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Authors:  Mojca Skoberne; Rhonda Cardin; Alexander Lee; Ana Kazimirova; Veronica Zielinski; Danielle Garvie; Amy Lundberg; Shane Larson; Fernando J Bravo; David I Bernstein; Jessica B Flechtner; Deborah Long
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.